Emcure Pharmaceuticals Limited (BOM:544210)
India · Delayed Price · Currency is INR 1,335.10
-4.85 (-0.36%)
At close: Oct 30, 2025
Emcure Pharmaceuticals Revenue
Emcure Pharmaceuticals had revenue of 21.01B INR in the quarter ending June 30, 2025, with 15.72% growth. This brings the company's revenue in the last twelve months to 81.81B, up 18.28% year-over-year. In the fiscal year ending March 31, 2025, Emcure Pharmaceuticals had annual revenue of 78.96B with 18.59% growth.
Revenue (ttm)
81.81B
Revenue Growth
+18.28%
P/S Ratio
3.06
Revenue / Employee
12.15M
Employees
6,731
Market Cap
250.02B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 78.96B | 12.38B | 18.59% |
| Mar 31, 2024 | 66.58B | 6.72B | 11.23% |
| Mar 31, 2023 | 59.86B | 1.30B | 2.23% |
| Mar 31, 2022 | 58.55B | 8.22B | 16.33% |
| Mar 31, 2021 | 50.33B | -150.80M | -0.30% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2012 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2011 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2010 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Reliance Industries | 10.00T |
| Life Insurance Corporation of India | 9.04T |
| State Bank of India | 3.50T |
| Larsen & Toubro | 2.76T |
| HDFC Bank | 2.68T |
| Tata Consultancy Services | 2.58T |
| ICICI Bank | 1.91T |
| Bharti Airtel | 1.84T |